Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chief counsel leaves FDA

This article was originally published in The Tan Sheet

Executive Summary

Sheldon Bradshaw, chief counsel of FDA, resigned from the agency Sept. 6 to join Hunton & Williams' food and drug law practice, according to the firm. A former Justice Department attorney, Bradshaw served as top lawyer at FDA since 2005, replacing Dan Troy (1"The Tan Sheet" April 11, 2005, p. 7). During his tenure, he reviewed and approved regulations and guidance including a proposed rule clarifying information included in new dietary ingredient notifications and a draft guidance on the kind of scientific data the FDA's Center for Food Safety and Applied Nutrition would find useful in new dietary ingredient submissions. Deputy Chief Counsel Jeffrey Senger will serve as acting chief until a permanent replacement is found, according to FDA staffers in the Office of Chief Counsel...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel